Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
ExonHit expands Splicearray Line on Affymetrix microarray platform
May 18th, 2006
ExonHit Therapeutics, a drug and diagnostic discovery company, announced that a number of its SpliceArray products are now available on the Affymetrix microarray platform. The announcement follows the supply and provider agreement between ExonHit and Affymetrix signed last October. ExonHit's SpliceArrays that are now available on the Affymetrix GeneChip platform include ExonHit's SpliceArrays for GPCR, Ion Channel, nuclear receptors and apoptosis pathways. Custom arrays are also available. SpliceArrays are a new generation of microarrays that resolve the expression of genes at the level of their alternatively spliced transcripts....
Source: Biotech Business Week (2006-05-18)
|
